Search results for: Frederique Lang
Filter search results
Lung Cancer’s Biggest Test: How Can We Mobilise NGS Testing to Transform Lung Cancer Care?
7 December 2023, 12:00am
…is interested in the development of new anti-cancer drugs for patients with lung malignancies. He is also the Joint Chief Investigator for the CONCORDE platform. Professor Frederique Penault- Llorca |…
Effective Commissioning: Lessons from purchasing in American managed care
1 June 1998
…Discussing fundamentals, however, raises a problem about language. I do not mean the problem of figuring out how one can not only put a boot in a trunk but a…
Risk and Return in the Pharmaceutical Industry
1 August 1999
This book has been built up from the papers delivered at the Office of Health Economics conference which took place at the Langham Hilton Hotel, London, on 5 December 1996….
Pharmaceutical Prices: A continental view
1 April 1978
…because it is a useful compilation of many arguments relating to pharmaceutical pricing, which deserves to be available in the English language as well as in German. It is also…
Dictionary
…health economics. Designed to enhance understanding, this resource acts as a go-to guide for professionals, students, and enthusiasts alike, providing clarity and insight into the complex language of health economics….
Parkinson’s Disease
1 October 1991
…for the present an incurable malady even if its progression may be slowed and disabling symptoms ameliorated. As Langston (1990) says, ‘ … although we may still be far from…
Financing Health Care in the UK: A Discussion of NERA’s Prototype Model to Replace the NHS
1 January 1995
…emphasised technical progress increased expectations of life, and rising expectations as causes of the underlying problem. To the layman this may seem a strange use of language since all of…
Consolidation and Competition in the Pharmaceutical Industry
9 January 2001
…policies in the US and EU are explored. In addition to assessing the competitive implications of traditional merger and acquisition activity, both Levy and Langeheine point out that regulators on…